A reply to "Randomized controlled clinical trial is needed for toxicity of IMRT VS 3D-CRT in PORT for LA-NSCLC". Jairam V, Soulos PR, Gross CP, Yu JB, et al. Lung Cancer 2022;168:84-85.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jairam V, Soulos PR, Gross CP, Yu JB, et al. A reply to "Randomized controlled clinical trial is needed for toxicity of IMRT VS 3D-CRT in PORT for LA-NSCLC". Lung Cancer 2022;168:84-85.
PMID: 34933760